CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
We recently published a list of 10 Hottest Large-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...
The accused killer of Brian Thompson cited the industry’s failures as his motive for assassinating the UnitedHealth executive ...
CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback